BeOne Medicines Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $17.3M | $352.9M | $87.5M |
| FY2017 | $9.2M | $669.8M | $239.6M |
| FY2018 | $40.8M | $1.74B | $712.9M |
| FY2019 | $83.3M | $962.2M | $618.0M |
| FY2020 | $183.6M | $3.87B | $1.38B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $17.3M | $352.9M | $87.5M |
| FY2017 | $9.2M | $669.8M | $239.6M |
| FY2018 | $40.8M | $1.74B | $712.9M |
| FY2019 | $83.3M | $962.2M | $618.0M |
| FY2020 | $183.6M | $3.87B | $1.38B |